Triumph Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.32K Hold
100
– – ﹤0.01% 1512
2026
Q2
$3.71K Hold
100
– – ﹤0.01% 1448
2026
Q1
$3.38K Hold
100
– – ﹤0.01% 1429
2025
Q4
$2.72K Buy
+100
New +$3.51K ﹤0.01% 1418

Other funds holding AGIO

Triumph Capital Management's AGIO Position: Q3 2026 in Review

Triumph Capital Management held its Agios Pharmaceuticals (AGIO) position steady in Q3 2026 at 100 shares worth $3.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

Triumph Capital Management first reported a position in AGIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.71K in Q2 2026. 241 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Triumph Capital Management held 100 shares of Agios Pharmaceuticals worth $3.32K as of Q3 2026.
  • Triumph Capital Management left its Agios Pharmaceuticals share count unchanged in Q3 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1512 holding.
  • Triumph Capital Management first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Triumph Capital Management's Agios Pharmaceuticals position peaked at $3.71K in Q2 2026.
  • 241 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.